Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0781-3491

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 0781-3491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidine-carton-lbl.jpg (Azacitidine Carton Lbl)

Azacitidine-carton-lbl.jpg (Azacitidine Carton Lbl)
This is product labeling information for Azacitidine for Injection, a cytotoxic agent used for subcutaneous and intravenous administration. The medication comes in a sterile single-dose vial containing 100 mg of azacitidine and 100 mg of mannitol. The vial should be discarded if unused and kept out of reach of children. The recommended storage temperature is 25°C (77°F) with permitted excursions between 15 to 30°C (59 to 86°F). The product is manufactured by MSN Laboratories Private Limited in Telangana, India, for Sandoz Inc. in Princeton, NJ.*
FDA Label Image

Azacitidine-figure (Azacitidine Figure)

Azacitidine-figure (Azacitidine Figure)
The provided text presents the results of a statistical analysis, indicating a Log-Rank p-value of 0.0001, which suggests a significant difference between the compared groups. Furthermore, the Hazard Ratio (HR) is reported as 0.5895 with a confidence interval of 0.43-0.77. The number of deaths in each group is also provided, with 82 in the Aza group and 113 in the CCR group. The data includes a graphical representation of time (in months) from randomization and the number of individuals at risk in each group at different time points.*
FDA Label Image

Azacitidine-structure (Azacitidine Structure)

FDA Label Image

Azacitidine-vial-lbl.jpg (Azacitidine Vial Lbl)

Azacitidine-vial-lbl.jpg (Azacitidine Vial Lbl)
This is a description of Azacitidine, available in a single-dose vial containing 100 mg per vial for subcutaneous and intravenous use. It is a cytotoxic agent manufactured by MSN Laboratories Private Limited in Telangana, India. The usual dosage information can be found in the prescribing information provided by Sandoz Inc. It is important to discard any unused portion, keep out of reach of children, and store at controlled room temperature.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.